Loading data
PHIONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 4.62 m USD | 3.64 m USD | 6.33 m USD | 7.01 m USD | 8.89 m USD |
| Operating profit | -9.22 m USD | -7.39 m USD | -10.82 m USD | -11.46 m USD | -13.51 m USD |
| Profit before tax | — | — | — | -11.48 m USD | -13.29 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -8.7 m USD | -7.15 m USD | -10.83 m USD | -11.48 k USD | -13.29 m USD |
| Basic earnings per share | -1.45 USD/share | -9.08 USD/share | -46.76 USD/share | -10.1 USD/share | -12.43 USD/share |
| Diluted earnings per share | — | -9.08 USD/share | -46.76 USD/share | -10.1 USD/share | -12.43 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.